Lysophosphatidic acid increases phosphatidic acid formation, phospholipase D activity and degranulation by human neutrophils

Cell Signal. 2005 Jan;17(1):77-82. doi: 10.1016/j.cellsig.2004.06.003.

Abstract

I-oleoyl-sn-glycero-3-phosphate, a lysophosphatidic acid (LPA), in serum is a biologically active lipid and has multiple functions depending on the cell types. Several studies have shown that LPA stimulates phospholipase D (PLD) activity in fibroblasts and prostate cancer cells in culture. PLD plays a central role in regulating neutrophil functions. One of the functions of the lipid product, phosphatidic acid (PA), of PLD action in neutrophils is to promote degranulation. In the present study, we examined the effect of LPA on PLD activity and degranulation by human neutrophils. The results show that exogenous LPA increased PA formation, PLD activity and degranulation by human neutrophils in a time and concentration dependent manner. These findings suggest that LPA released from activated platelets during blood clotting may participate in bacterial killing and wound healing process. On the other hand, augmented LPA production might be involved in inflammation, causing damage of the host tissues.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Glucuronidase / blood
  • Glucuronidase / drug effects
  • Humans
  • Kinetics
  • L-Lactate Dehydrogenase / blood
  • L-Lactate Dehydrogenase / drug effects
  • Lysophospholipids / pharmacology*
  • Neutrophils / drug effects
  • Neutrophils / physiology*
  • Phosphatidic Acids / blood*
  • Phospholipase D / blood*

Substances

  • Lysophospholipids
  • Phosphatidic Acids
  • L-Lactate Dehydrogenase
  • Phospholipase D
  • Glucuronidase
  • lysophosphatidic acid